Health In Tech Stock Performance
| HIT Stock | 1.19 0.03 2.59% |
The company retains a Market Volatility (i.e., Beta) of 0.96, which attests to possible diversification benefits within a given portfolio. Health In returns are very sensitive to returns on the market. As the market goes up or down, Health In is expected to follow. At this point, Health In Tech has a negative expected return of -1.0%. Please make sure to check out Health In's rate of daily change, period momentum indicator, as well as the relationship between the potential upside and jensen alpha , to decide if Health In Tech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Health In Tech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Acquisition by Clarkson Michael David of 8000 shares of Health In subject to Rule 16b-3 | 11/05/2025 |
2 | Cheche Group versus Health In Tech Financial Contrast | 11/18/2025 |
3 | TEM vs. BFLY Which Stock Offers Greater Upside Amid Health Tech Boom - Yahoo Finance | 11/24/2025 |
4 | Head to Head Analysis Cheche Group vs. Health In Tech | 11/28/2025 |
5 | Well Health Stock Buy, Sell, or Hold In 2026 - fool.ca | 12/05/2025 |
6 | Bio-Techne Stock Is TECH Underperforming the Healthcare Sector - Yahoo Finance | 12/16/2025 |
7 | Insider Trading | 12/26/2025 |
8 | Acquisition by Qian Linlin of 80000 shares of Health In subject to Rule 16b-3 | 12/30/2025 |
9 | Acquisition by Qian Linlin of 1000000 shares of Health In subject to Rule 16b-3 | 01/06/2026 |
10 | Health In Tech Collaborates with Benefit Re to Launch Over 100 Customized Stop-Loss Self-Funded Healthcare Plans for Employers | 01/07/2026 |
11 | Health In Tech Announces Zain Hasan as Chief Growth Officer to Accelerate Revenue Growth and Scale Distribution | 01/13/2026 |
12 | Investors in HiTech Group Australia have unfortunately lost 6.8 percent over the last three years | 01/29/2026 |
| Begin Period Cash Flow | 2.4 M | |
| Total Cashflows From Investing Activities | -836.8 K |
Health In Relative Risk vs. Return Landscape
If you would invest 270.00 in Health In Tech on November 3, 2025 and sell it today you would lose (151.00) from holding Health In Tech or give up 55.93% of portfolio value over 90 days. Health In Tech is generating negative expected returns assuming volatility of 7.7947% on return distribution over 90 days investment horizon. In other words, 70% of stocks are less volatile than Health, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Health In Target Price Odds to finish over Current Price
The tendency of Health Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.19 | 90 days | 1.19 | about 80.98 |
Based on a normal probability distribution, the odds of Health In to move above the current price in 90 days from now is about 80.98 (This Health In Tech probability density function shows the probability of Health Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Health In has a beta of 0.96. This usually indicates Health In Tech market returns are related to returns on the market. As the market goes up or down, Health In is expected to follow. Additionally Health In Tech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Health In Price Density |
| Price |
Predictive Modules for Health In
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Health In Tech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Health In Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Health In is not an exception. The market had few large corrections towards the Health In's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Health In Tech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Health In within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.11 | |
β | Beta against Dow Jones | 0.96 | |
σ | Overall volatility | 0.57 | |
Ir | Information ratio | -0.14 |
Health In Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Health In for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Health In Tech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Health In Tech generated a negative expected return over the last 90 days | |
| Health In Tech has high historical volatility and very poor performance | |
| Health In Tech may become a speculative penny stock | |
| Health In Tech is unlikely to experience financial distress in the next 2 years | |
| Health In Tech has a strong financial position based on the latest SEC filings | |
| About 75.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Teads Holding Has A Somewhat Strained Balance Sheet |
Health In Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Health Stock often depends not only on the future outlook of the current and potential Health In's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Health In's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.7 M | |
| Cash And Short Term Investments | 7.8 M |
Health In Fundamentals Growth
Health Stock prices reflect investors' perceptions of the future prospects and financial health of Health In, and Health In fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0533 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 59.86 M | ||||
| Shares Outstanding | 45.21 M | ||||
| Price To Earning | 24.13 X | ||||
| Price To Book | 3.95 X | ||||
| Price To Sales | 2.20 X | ||||
| Revenue | 19.49 M | ||||
| Gross Profit | 20.61 M | ||||
| EBITDA | 1.93 M | ||||
| Net Income | 670.48 K | ||||
| Cash And Equivalents | 7.05 B | ||||
| Cash Per Share | 15.61 X | ||||
| Total Debt | 206.69 K | ||||
| Debt To Equity | 1.14 % | ||||
| Current Ratio | 1.17 X | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | 2.18 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Market Capitalization | 67.72 M | ||||
| Total Asset | 15.77 M | ||||
| Retained Earnings | 3.94 M | ||||
| Working Capital | 8.65 M | ||||
| Current Asset | 59.12 B | ||||
| Current Liabilities | 49.33 B | ||||
About Health In Performance
Assessing Health In's fundamental ratios provides investors with valuable insights into Health In's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Health In is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.10 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.04 | 0.07 | |
| Return On Equity | 0.06 | 0.06 |
Things to note about Health In Tech performance evaluation
Checking the ongoing alerts about Health In for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Health In Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health In Tech generated a negative expected return over the last 90 days | |
| Health In Tech has high historical volatility and very poor performance | |
| Health In Tech may become a speculative penny stock | |
| Health In Tech is unlikely to experience financial distress in the next 2 years | |
| Health In Tech has a strong financial position based on the latest SEC filings | |
| About 75.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Teads Holding Has A Somewhat Strained Balance Sheet |
- Analyzing Health In's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health In's stock is overvalued or undervalued compared to its peers.
- Examining Health In's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health In's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health In's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Health In's stock. These opinions can provide insight into Health In's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.